Pfizer Acquires Redvax for Vaccine Platform

Pfizer acquired a controlling interest in privately held Redvax, a move that gives the increasingly vaccine-focused drug giant access to a potential vaccine against a herpes virus.



from WSJ.com: US Business http://ift.tt/1wdn2Ry

via IFTTT